Talk
Oral Communications
Wed, Nov 18, 2026 · 8:30–9:30 AM EST Ballroom - 4th floor, Boston Marriott Copley Place
About this session
Oral communications: OC19 Brain-Derived pTau217 Outperforms 328 Plasma Proteins for Association with Amyloid and Tau Accumulation and Cognitive Progression in the A4 and LEARN Studies; OC20 Tau stable isotope labelling kinetics (SILK) and fluid biomarker response to NIO752 – tau MAPT antisense oligonucleotide: an unblinded interim analysis of a phase 1B trial in Alzheimer's disease; OC21 Psychosis symptoms associated with AD improve with short- and long-term open-label KarXT treatment; OC22 Estimating 15-Year absolute risk of cognitive impairment in cognitively unimpaired older adults with Alzheimer disease biomarkers based on amyloid PET or plasma %p-tau217.
Speakers
-
University of Southern California
Chair
-
Joy Chambers-Grundy Professor of Brain Science; Director, Chambers-Grundy Center for Transformative Neuroscience · University of Nevada Las Vegas (UNLV)
Chair